Logo image of CNK

CINEMARK HOLDINGS INC (CNK) Stock Fundamental Analysis

NYSE:CNK - New York Stock Exchange, Inc. - US17243V1026 - Common Stock - Currency: USD

29.02  +0.19 (+0.66%)

After market: 28.52 -0.5 (-1.72%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CNK. CNK was compared to 71 industry peers in the Entertainment industry. There are concerns on the financial health of CNK while its profitability can be described as average. CNK is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CNK had positive earnings in the past year.
In the past year CNK had a positive cash flow from operations.
In multiple years CNK reported negative net income over the last 5 years.
CNK had a positive operating cash flow in 4 of the past 5 years.
CNK Yearly Net Income VS EBIT VS OCF VS FCFCNK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M -600M

1.2 Ratios

CNK has a Return On Assets of 4.78%. This is amongst the best in the industry. CNK outperforms 81.82% of its industry peers.
CNK has a Return On Equity of 42.23%. This is amongst the best in the industry. CNK outperforms 93.94% of its industry peers.
CNK has a better Return On Invested Capital (6.68%) than 78.79% of its industry peers.
Industry RankSector Rank
ROA 4.78%
ROE 42.23%
ROIC 6.68%
ROA(3y)-3.23%
ROA(5y)-3.49%
ROE(3y)-104.01%
ROE(5y)-75.3%
ROIC(3y)N/A
ROIC(5y)N/A
CNK Yearly ROA, ROE, ROICCNK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200

1.3 Margins

The Profit Margin of CNK (8.20%) is better than 84.85% of its industry peers.
CNK's Profit Margin has declined in the last couple of years.
CNK has a Operating Margin of 10.15%. This is in the better half of the industry: CNK outperforms 77.27% of its industry peers.
CNK's Operating Margin has declined in the last couple of years.
The Gross Margin of CNK (64.89%) is better than 75.76% of its industry peers.
CNK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.15%
PM (TTM) 8.2%
GM 64.89%
OM growth 3YN/A
OM growth 5Y-3.2%
PM growth 3YN/A
PM growth 5Y-1.8%
GM growth 3Y-0.58%
GM growth 5Y0.38%
CNK Yearly Profit, Operating, Gross MarginsCNK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CNK is destroying value.
CNK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CNK has more shares outstanding
The debt/assets ratio for CNK has been reduced compared to a year ago.
CNK Yearly Shares OutstandingCNK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CNK Yearly Total Debt VS Total AssetsCNK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that CNK is in the distress zone and has some risk of bankruptcy.
CNK's Altman-Z score of 1.20 is in line compared to the rest of the industry. CNK outperforms 50.00% of its industry peers.
CNK has a debt to FCF ratio of 10.72. This is a negative value and a sign of low solvency as CNK would need 10.72 years to pay back of all of its debts.
CNK has a Debt to FCF ratio of 10.72. This is comparable to the rest of the industry: CNK outperforms 59.09% of its industry peers.
CNK has a Debt/Equity ratio of 3.52. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CNK (3.52) is worse than 77.27% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.52
Debt/FCF 10.72
Altman-Z 1.2
ROIC/WACC0.89
WACC7.51%
CNK Yearly LT Debt VS Equity VS FCFCNK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

CNK has a Current Ratio of 0.98. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
CNK has a Current ratio of 0.98. This is comparable to the rest of the industry: CNK outperforms 51.52% of its industry peers.
CNK has a Quick Ratio of 0.98. This is a bad value and indicates that CNK is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.96, CNK perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.98
Quick Ratio 0.96
CNK Yearly Current Assets VS Current LiabilitesCNK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 176.79% over the past year.
The Earnings Per Share has been decreasing by -8.99% on average over the past years.
CNK shows a decrease in Revenue. In the last year, the revenue decreased by -5.07%.
CNK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.98% yearly.
EPS 1Y (TTM)176.79%
EPS 3YN/A
EPS 5Y-8.99%
EPS Q2Q%95.08%
Revenue 1Y (TTM)-5.07%
Revenue growth 3Y64.71%
Revenue growth 5Y-0.98%
Sales Q2Q%5.37%

3.2 Future

CNK is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.65% yearly.
Based on estimates for the next years, CNK will show a small growth in Revenue. The Revenue will grow by 1.80% on average per year.
EPS Next Y66.92%
EPS Next 2Y28.44%
EPS Next 3Y24.65%
EPS Next 5Y0.65%
Revenue Next Year-0.88%
Revenue Next 2Y4.9%
Revenue Next 3Y5.27%
Revenue Next 5Y1.8%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CNK Yearly Revenue VS EstimatesCNK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CNK Yearly EPS VS EstimatesCNK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.72 indicates a rather expensive valuation of CNK.
Based on the Price/Earnings ratio, CNK is valued cheaply inside the industry as 81.82% of the companies are valued more expensively.
CNK is valuated rather cheaply when we compare the Price/Earnings ratio to 28.28, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 14.30, the valuation of CNK can be described as correct.
Based on the Price/Forward Earnings ratio, CNK is valued cheaply inside the industry as 86.36% of the companies are valued more expensively.
CNK's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 91.29.
Industry RankSector Rank
PE 18.72
Fwd PE 14.3
CNK Price Earnings VS Forward Price EarningsCNK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CNK is valued a bit cheaper than 78.79% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNK indicates a rather cheap valuation: CNK is cheaper than 81.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.57
EV/EBITDA 10.29
CNK Per share dataCNK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CNK may justify a higher PE ratio.
CNK's earnings are expected to grow with 24.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y28.44%
EPS Next 3Y24.65%

0

5. Dividend

5.1 Amount

No dividends for CNK!.
Industry RankSector Rank
Dividend Yield N/A

CINEMARK HOLDINGS INC

NYSE:CNK (1/29/2025, 8:15:00 PM)

After market: 28.52 -0.5 (-1.72%)

29.02

+0.19 (+0.66%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-31 2024-10-31/bmo
Earnings (Next)02-21 2025-02-21/amc
Inst Owners118.8%
Inst Owner Change0.28%
Ins Owners2.44%
Ins Owner Change-3.61%
Market Cap3.55B
Analysts73.33
Price Target33.85 (16.64%)
Short Float %22.91%
Short Ratio10.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)181.96%
Min EPS beat(2)109.69%
Max EPS beat(2)254.24%
EPS beat(4)3
Avg EPS beat(4)137.58%
Min EPS beat(4)-12.61%
Max EPS beat(4)254.24%
EPS beat(8)6
Avg EPS beat(8)54.89%
EPS beat(12)7
Avg EPS beat(12)13.13%
EPS beat(16)7
Avg EPS beat(16)5%
Revenue beat(2)2
Avg Revenue beat(2)4.15%
Min Revenue beat(2)3.21%
Max Revenue beat(2)5.09%
Revenue beat(4)4
Avg Revenue beat(4)3.18%
Min Revenue beat(4)2.08%
Max Revenue beat(4)5.09%
Revenue beat(8)7
Avg Revenue beat(8)3.29%
Revenue beat(12)11
Avg Revenue beat(12)3.59%
Revenue beat(16)14
Avg Revenue beat(16)8.78%
PT rev (1m)2.82%
PT rev (3m)12.48%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-30.64%
EPS NY rev (1m)0%
EPS NY rev (3m)53.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.52%
Valuation
Industry RankSector Rank
PE 18.72
Fwd PE 14.3
P/S 1.24
P/FCF 15.57
P/OCF 9.39
P/B 6.36
P/tB N/A
EV/EBITDA 10.29
EPS(TTM)1.55
EY5.34%
EPS(NY)2.03
Fwd EY6.99%
FCF(TTM)1.86
FCFY6.42%
OCF(TTM)3.09
OCFY10.65%
SpS23.49
BVpS4.56
TBVpS-8.08
PEG (NY)0.28
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.78%
ROE 42.23%
ROCE 7.72%
ROIC 6.68%
ROICexc 8.86%
ROICexgc 19.36%
OM 10.15%
PM (TTM) 8.2%
GM 64.89%
FCFM 7.94%
ROA(3y)-3.23%
ROA(5y)-3.49%
ROE(3y)-104.01%
ROE(5y)-75.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-1.28%
ROICexc growth 3YN/A
ROICexc growth 5Y-2.31%
OM growth 3YN/A
OM growth 5Y-3.2%
PM growth 3YN/A
PM growth 5Y-1.8%
GM growth 3Y-0.58%
GM growth 5Y0.38%
F-Score6
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 3.52
Debt/FCF 10.72
Debt/EBITDA 4.01
Cap/Depr 75.68%
Cap/Sales 5.22%
Interest Coverage 1.96
Cash Conversion 77.16%
Profit Quality 96.73%
Current Ratio 0.98
Quick Ratio 0.96
Altman-Z 1.2
F-Score6
WACC7.51%
ROIC/WACC0.89
Cap/Depr(3y)51.28%
Cap/Depr(5y)60.48%
Cap/Sales(3y)5.24%
Cap/Sales(5y)7.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)176.79%
EPS 3YN/A
EPS 5Y-8.99%
EPS Q2Q%95.08%
EPS Next Y66.92%
EPS Next 2Y28.44%
EPS Next 3Y24.65%
EPS Next 5Y0.65%
Revenue 1Y (TTM)-5.07%
Revenue growth 3Y64.71%
Revenue growth 5Y-0.98%
Sales Q2Q%5.37%
Revenue Next Year-0.88%
Revenue Next 2Y4.9%
Revenue Next 3Y5.27%
Revenue Next 5Y1.8%
EBIT growth 1Y-17.78%
EBIT growth 3YN/A
EBIT growth 5Y-4.15%
EBIT Next Year63.26%
EBIT Next 3Y29.39%
EBIT Next 5Y11.82%
FCF growth 1Y72.12%
FCF growth 3YN/A
FCF growth 5Y6.94%
OCF growth 1Y60.13%
OCF growth 3YN/A
OCF growth 5Y-4.42%